Pubblicazioni

Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study

2024 - MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

Passucci, Mauro; Fazio, Francesca; Micozzi, Jacopo; Bafti, Manhaz Shafii; Assanto, Giovanni; Piciocchi, Alfonso; Martelli, Maurizio; Petrucci, Maria Teresa

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells

2024 - CLINICAL AND TRANSLATIONAL IMMUNOLOGY

Klaâ¬sener, Kathrin; Herrmann, Nadja; H#aversen, Liliana; Sundell, Timothy; Sundqvist, Martina; Lundqvist, Christina; T Manna, Paul; A Jonsson, Charlotte; Visentini, Marcella; Ljung Sass, Diana; Mcgrath, Sarah; Grimstad, Kristoffer; Aranburu, Alaitz; Mellgren, Karin; Fogelstrand, Linda; Forsman, Huamei; Ekwall, Olov; BorÃ©n, Jan; Gjertsson, Inger; Reth Inga-Lill M#artensson, Michael; Camponeschi, Alessandro

Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma. A âreal worldâ experience

2022 - LEUKEMIA RESEARCH REPORTS

Fucci, Ludovica; Gensini, Lorenzo; Coppetelli, Ugo; Ortu La Barbera, Elettra; Gentile, Martina; Fiori, Luciano; Perrone, Salvatore; Cimino, Giuseppe

CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment

2022 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Swan, D; Henderson, R; Mcellistrim, C; Naicker, S D; Quinn, J; Cahill, M R; Mykytiv, V; Lenihan, E; Mulvaney, E; Nolan, M; Parker, I; Natoni, A; Lynch, K; Ryan, A E; Szegezdi, E; Krawczyk, J; Murphy, P; O'Dwyer, M

Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis

2021 - ONCOIMMUNOLOGY

Naicker, Serika D; Feerick, Claire L; Lynch, Kevin; Swan, Dawn; Mcellistrim, Cian; Henderson, Robert; Leonard, Niamh A; Treacy, Oliver; Natoni, Alessandro; Rigalou, Athina; Cabral, Joana; Chiu, Christopher; Sasser, Kate; Ritter, Thomas; O'Dwyer, Michael; Ryan, Aideen E

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment

2020 - PHARMACEUTICALS

MorÃ¨, Sonia; Petrucci, Maria Teresa; Corvatta, Laura; Fazio, Francesca; Offdani, Massimo; Olivieri, Attilio

The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide

2020 - CANCER IMMUNOLOGY, IMMUNOTHERAPY

Sarkar, Subhashis; Chauhan, Sachin K S; Daly, John; Natoni, Alessandro; Fairfield, Heather; Henderson, Robert; Nolan, Emma; Swan, Dawn; Hu, Jinsong; Reagan, Michaela R; O'Dwyer, Michael